FC
Therapeutic Areas
IMIDomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed First-in-Class Programs | Systemic Lupus Erythematosus, Ulcerative Colitis, Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Atopic Dermatitis, Sjögren’s Syndrome | Pre-clinical |